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Abstract:  Ovarian Toxicity of 2-Bromopropane in the
Non-Pregnant Female Rat: Michihiro KAMIJIMA, et al.
Department of Hygiene, Nagoya University School of
Medicine—A cluster of patients with amenorrhea,
oligospermia and anemia were found among workers in
an electronics factory in the Republic of Korea.  2-
Bromopropane was suspected to cause the disorders.
This study aimed to clarify its ovarian toxicity in the virgin
rat.  Female Wistar rats were daily exposed to 0, 100,
300, or 1,000 ppm 2-bromopropane for eight hours a day
for 9 weeks.  During the experimental period, vaginal
smears were taken everyday to monitor ovarian cyclicity.
Tissues were histopathologically examined and plasma
concentrations of luteinizing hormone (LH) and follicle-
stimulating hormone (FSH) were determined at the end
of experiment.  The vaginal smear test showed that the
number of normal cycles decreased significantly both in
the 300 and 1,000 ppm groups.  The histopathological
examination revealed dose-dependent ovarian follicle
atresia accompanied by a decreased number of normal
antral and growing follicles in the 300 and 1,000 ppm
groups.  Especially, in the ovaries of rats with persistent
estrous smears in the 1,000 ppm group, most of the
follicles were atretic and there were no newly formed
corpora lutea.  There still remained normal antral follicles
and corpora lutea in the ovaries of the remaining rats of
the group and of the 300 ppm group with constant
diestrous and occasional estrous smears.  Hormonal
examination revealed no statistically significant change
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in LH or FSH concentrations between any groups.  The
results showed that 2-bromopropane has ovarian toxicity
in rats, indicating that the secondary amenorrhea in human
cases was due to 2-bromopropane exposure.
(J Occup Health 1997; 39: 144–149)
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In 1995, a cluster of patients with amenorrhea,
oligospermia and anemia were found among workers in an
electronics factory in the Republic of Korea.  The workers
affected were all exposed to 2-bromopropane-containing
solvents.  2-Bromopropane was used as an alternative to
ozone layer-depleting freon. Though neither reproductive
nor hematopoietic toxicity of the solvent had been reported
before that, 2-bromopropane was considered as the most
probable cause of the disorders from a cross-sectional
survey1).  Thus, animal experiments were conducted to
clarify the toxicity of 2-bromopropane.
Our first study in male rats showed that 2-bromopropane
impaired spermatogenesis and hematopoiesis dose-
dependently2,3).  The second study in female rats revealed
that 2-bromopropane disrupted estrous cyclicity, which we
reported in the preliminary paper4).  In the present paper, we
extensively clarified that 2-bromopropane has ovarian
toxicity in the virgin rat.
Materials and Methods
Chemical:  2-Bromopropane (99.4% purity) was obtained
from Tosoh Co., Japan.
Animals:  Female rats (slc:Wistar/ST) were obtained from
SLC (Shizuoka Laboratory Animal Center, Japan).  Animals
were housed in stainless steel chambers, provided food and
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water ad libitum, and maintained under controlled conditions
of light (12-hr/12-hr, light/dark cycle, lights off at 9:00 PM),
temperature (22–25°C) and humidity (57–60%).  Japanese
law concerning the protection and control of animals, the
standards relating to the care and management of
experimental animals, and the Animal Experimental Guide
of Nagoya University School of Medicine were followed in
this experiment.
Animal treatments:  Thirty-six rats, weighing 230–270 g
at 12 weeks of age, were divided into four groups of nine
after acclimatizing them to conditions.  After monitoring
pretreatment estrous cycle in every rat for three weeks, each
group was daily exposed to 0, 100, 300, or 1,000 ppm 2-
bromopropane for eight hours a day (from 2:00 to 10:00
PM) in the chambers.  These concentrations were selected
according to our previous study on male rats, in which all
rats exposed at 3,000 ppm 2-bromopropane became seriously
ill and spermatogenesis was impaired at 300 ppm or more3).
The inhalation exposure system has been described in detail
elsewhere3,5).  Vapor concentrations were measured with gas
chromatography and controlled to be within ± 5% of the
target concentrations by a personal computer system.  During
the experimental period, vaginal smears were taken every
day to monitor ovarian cyclicity, and all the rats were
weighed once every week.  After the exposure for 9 weeks,
the rats were decapitated on the day of diestrus 1 during the
10th week.  Blood was collected for hormonal assay.  Organs
were removed and weighed immediately and fixed in 10%
neutral-buffered formalin for light microscopic evaluation.
When the smears showed disrupted estrous cyclicity, i.e.
constant estrus or constant diestrus, the rats were sacrificed
on the day of estrus or diestrus, respectively.  The exposure
was continued until the day before autopsy.
Vaginal smears:  Daily vaginal smears were taken between
10:00 and 11:00 AM6).  They were stained with methylene
blue (Katayama Chemical, Japan) solution and observed
under a microscope.  The 12-week experimental period was
divided into four consecutive 3-week periods, one pre-
exposure period and three exposure periods.  Then the
number of normal estrous cycles that started with smears
characteristic of estrus was counted in each rat throughout
the periods.  The cycles were regarded as normal when they
showed typical stages of proestrus, estrus and diestrus6,7),
which was usually observed with a four- to six-day cycle.
When a cycle extended from one period to another, the cycle
was counted as 0.5 cycle in each period.
Tissue preparation:  After fixation, tissues were
dehydrated in graded concentrations of alcohol, embedded
in paraffin, sectioned at 6 µm, then stained with hematoxylin-
eosin.
Hormonal assay:  Concentrations of luteinizing hormone
(LH) and follicle-stimulating hormone (FSH) in 50 µl plasma
samples were determined by a double-antibody
radioimmunoassay (RIA) using rat LH and FSH RIA kits
supplied by the National Hormone and Pituitary Program
(Baltimore, MD).  The values were expressed in terms of
NIDDK-rLH-RP-3 and NIDDK-rFSH-RP-2, respectively.
The least detectable levels of LH and FSH were 0.16 ng/ml
and 2.5 ng/ml, respectively.
Data analysis:  The rats without regular estrous cycles
during the pre-exposure period were discarded from the
analysis for estrous cycle, organ weight, and hormonal
concentration.  One rat in the 300 ppm group was also
discarded from the analysis for organ weight and hormonal
concentration because the rat did not have the left kidney,
left ovary, or left uterine horn.  The differences in body
weight, organ weight, and hormonal concentration between
the exposed groups and the control group were analyzed by
ANOVA followed by Dunnett’s multiple comparison
method.  The number of estrous cycles after exposure was
compared to that before exposure by Kruskal-Wallis test
followed by Dunnett-type multiple comparison method.
Results
The vapor concentrations in exposed groups were 1,025
± 34 ppm, 299 ± 9 ppm, and 98 ± 3 ppm (mean ± S.D.),
respectively.  All the animals survived until the end of the
experiment.  The rats in the 1,000 ppm group did not move
around in the cage as much as those in other groups during
the exposure period.  Muscle tonus gradually decreased in
the 1,000 ppm group, and body weight gain in the group
was significantly suppressed compared to the control group.
Fig. 1. Change in body weight.  After monitoring the estrous
cycle for three weeks, each group was daily exposed to
0, 100, 300, or 1,000 ppm 2-bromopropane for 8 hours
a day, for 9 weeks.  Each point is the mean.
*Significantly different from the control group (p<0.05
by Dunnett’ s multiple comparison).
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Body weights of the other two groups did not significantly
differ from the control (Fig. 1).
The vaginal smear test showed that the estrous cycles in
the 1,000 ppm group began to prolong around the 2nd week
of exposure, and the number of normal cycles decreased
significantly in the last two periods (Table 1).  During the
periods, five rats in the group displayed constant diestrous
smears with occasional estrous ones, while the remaining
four rats in the group had constant estrous smears with
occasional diestrous ones.  In the 300 ppm group, the estrous
cycles were gradually prolonged around the 7th week
resulting from the prolonged diestrus.  During the last period,
all the rats displayed constant diestrus with occasional estrus.
The average interval of the estrous days in the period was
12.4 days in this group.  In the 100 ppm group, there was no
significant change in the number of normal cycles (Table
1).
Analysis of organ weights revealed that the ovary weight
tended to decrease in the 1,000 ppm group.  The weight of
uterus did not change significantly (Table 2).  However,
when compared among the rats autopsied on the day of
diestrus, the uterine weight significantly decreased in the
300 and 1,000 ppm groups compared to the control group
(Table 3).
Table 1.   Changes of estrous cycles by 2-bromopropane exposure
Weeks of exposure
Before exposure 1–3 Weeks 4–6 Weeks 7–9 Weeks
Number of rats
None Irregular Regular None Irregular Regular None Irregular Regular None Irregular Regular
0 ppm (n=7) 0 0 7 0 0 7 0 0 7 0 2 5
100 ppm (n=8) 0 0 8 0 0 8 0 0 8 1 0 7
300 ppm (n=8) 0 0 8 0 0 8 0 2 6 2 5     1**
1,000 ppm (n=9) 0 0 9 0 5 4 5 4     0** 8 1     0**
**p<0.01.  None: No normal estrous cycles (0 cycle/3 weeks).  Irregular: Irregular estrous cycles (0.5–3 cycles/3 weeks).  Regular:
Regular estrous cycles (3.5–5.5 cycles/3 weeks).
Table 2. Body weights and organ weights in rats exposed to 2-bromopropane after
exposure for 9 weeks
0 ppm 100 ppm 300 ppm 1,000 ppm
n 7 8 7 9
Body weight (g) 306.3 ± 29.8 300.0 ± 25.5 312.1 ± 25.0 275.0 ± 8.3*
Liver (g) 8.76 ± 1.36 8.85 ± 0.78 9.22 ± 0.72 8.70 ± 0.46
(28.5 ± 2.21) (29.5 ± 1.03) (29.6 ± 1.48) (31.7 ± 2.22*)
Spleen (g) 0.570 ± 0.078 0.557 ± 0.072 0.641 ± 0.146 0.424 ± 0.045**
(1.86 ± 0.18) (1.86 ± 0.18) (2.09 ± 0.65) (1.54 ± 0.16)
Thymus (g) 0.325 ± 0.042 0.297 ± 0.049 0.296 ± 0.078 0.158 ± 0.018**
(1.07 ± 0.18) (0.99 ± 0.15) (0.94 ± 0.22) (0.57 ± 0.06**)
Kidney Rt. (g) 0.887 ± 0.101 0.910 ± 0.078 0.898 ± 0.036 0.881 ± 0.087
(2.91 ± 0.33) (3.04 ± 0.15) (2.89 ± 0.22) (3.20 ± 0.27)
Lt. (g) 0.897 ± 0.090 0.905 ± 0.084 0.904 ± 0.041 0.877 ± 0.072
(2.94 ± 0.24) (3.02 ± 0.21) (2.91 ± 0.18) (3.19 ± 0.24)
Ovary Rt. (g) 0.039 ± 0.006 0.037 ± 0.013 0.041 ± 0.011 0.024 ± 0.007*
(0.13 ± 0.02) (0.12 ± 0.04) (0.13 ± 0.04) (0.09 ± 0.03)
Lt. (g) 0.038 ± 0.004 0.038 ± 0.013 0.040 ± 0.009 0.027 ± 0.010
(0.13 ± 0.01) (0.12 ± 0.04) (0.13 ± 0.03) (0.10 ± 0.03)
Uterus (g) 0.524 ± 0.098 0.580 ± 0.123 0.396 ± 0.059 0.392 ± 0.163
(1.72 ± 0.30) (1.95 ± 0.46) (1.27 ± 0.20) (1.43 ± 0.59)
Vagina (g) 0.153 ± 0.028 0.156 ± 0.026 0.161 ± 0.039 0.142 ± 0.025
(0.50 ± 0.08) (0.52 ± 0.06) (0.52 ± 0.12) (0.52 ± 0.08)
Relative organ weights are expressed in mg tissue weight/g body weight and indicated in
parentheses.  *p<0.05, **p<0.01.
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Table 3. Body weights and reproductive organ weights in the rats which showed diestrous
smears on the day of autopsy
0 ppm 100 ppm 300 ppm 1,000 ppm
n 7 7 7 5
Body weight (g) 306.3 ± 29.8 304.1 ± 24.5 312.1 ± 25.0 276.8 ± 9.8
Ovary Rt. (g) 0.039 ± 0.006 0.039 ± 0.013 0.041 ± 0.011 0.029 ± 0.004
(0.13 ± 0.02) (0.13 ± 0.04) (0.13 ± 0.04) (0.10 ± 0.01)
Lt. (g) 0.038 ± 0.004 0.039 ± 0.013 0.040 ± 0.009 0.034 ± 0.007
(0.13 ± 0.01) (0.13 ± 0.04) (0.13 ± 0.03) (0.12 ± 0.02)
Uterus (g) 0.524 ± 0.098 0.560 ± 0.118 0.396 ± 0.059* 0.263 ± 0.050**
(1.72 ± 0.30) (1.84 ± 0.38) (1.27 ± 0.20*) (0.95 ± 0.17**)
Vagina (g) 0.153 ± 0.028 0.158 ± 0.028 0.161 ± 0.039 0.136 ± 0.030
(0.50 ± 0.08) (0.52 ± 0.07) (0.52 ± 0.12) (0.49 ± 0.10)
Relative organ weights are expressed in mg tissue weight/g body weight and indicated in
parentheses.  *p<0.05, **p<0.01.
The histopathological examination revealed no abnormal
findings in organs other than those of the reproductive
system.  In the 1,000 ppm group, the most remarkable change
in the ovaries was widespread ovarian follicle atresia
accompanied by a decreased number of normal antral and
growing follicles.  In particular, in the ovaries of the four
persistent estrous rats, most of the follicles were atretic and
viable oocytes were hardly found in the remaining follicles.
Thin layers of granulosa cells were sometimes maintained
in the remaining cystic follicles.  There were no newly
formed corpora lutea.  On the other hand, normal antral
follicles and corpora lutea remained in the other five rats of
constant vaginal diestrus with occasional estrus.  However,
the number of antral and growing follicles was considerably
fewer than in the control.  Ovaries of the rats in the 300
ppm group displayed changes similar to those in the ovary
of the rats with constant diestrous smears in the 1,000 ppm
group (Fig. 2).
Hormonal examination revealed no statistically significant
change in plasma LH or FSH concentrations between any
groups.  However, LH tended to decrease dose-dependently
and FSH to increase dose-dependently in the 300 and 1,000
ppm groups (Tables 4, 5).
Discussion
The present study showed damage to the ovary and the
resulting disruption in estrous cyclicity due to 2-
bromopropane exposure at 300 ppm and 1,000 ppm in non-
pregnant female rats.  Although the rats exposed to 100 ppm
of 2-bromopropane did not show a significant decrease in
the number of normal estrous cycles as a whole, it seems
plausible that longer exposure at 100 ppm could cause
significant effects because it took about 7 weeks to detect
the effect of exposure at 300 ppm.
There were two types of disruption in the cyclicity of
rats in the 1,000 ppm group.  In one type, the rats showed
constant vaginal estrus without viable follicles and corpora
lutea in the ovary, which was indicative of anovulation; in
the other, we found constant diestrus and occasional estrus
with decreased viable follicles and corpora lutea, which was
similar to “ repetitive pseudopregnancies” 6) and indicative
of a decreased number of ovulations.  These two patterns
might be explained in terms of the extent of ovarian damage
and the cycle of follicular development.  Conceivably, 2-
bromopropane not only damages oocytes but interferes with
follicular maturation.  The partial loss of oocytes and delayed
follicular maturation would result in the prolonged diestrus
and the decrease in the number of ovulations and corpora
lutea.  The severer damage to oocytes would lead to follicular
atresia and cessation of development of antral follicles.  The
underdevelopment of the antral follicles would result in a
condition in which the blood concentration of estrogen would
not increase enough to cause the LH surge which is critical
for ovulation and corpora lutea formation.  On the other
hand, once the LH surge and the resulting formation of
corpora lutea occur, the insufficient estrogen production from
the next follicles would prevent corpora lutea from
diminishing.  In fact, the dose-dependent decrease in the
uterine weight among the diestrous rats indicated the
suppression of estrogen production in the rats of the 300
and 1,000 ppm group.  Interestingly, the plasma
concentration of FSH did not rise significantly despite the
severe damage to the ovaries.  The similar phenomenon was
also observed in rats treated with an antineoplastic alkylating
agent, cyclophosphamide, which suggested that the
mechanism of ovarian toxicity was different from that by
irradiation inducing high concentration of serum LH and
FSH8).
As for reproductive toxicity of other halogenated
propanes, 1,2-dibromo-3-chloropropane (DBCP) is known
as a potent testicular toxicant9).  However, the information
on female reproductive toxicity induced by DBCP or other
halogenated propanes is still scarce.  One study reported
that DBCP was not likely to affect oogenesis and ova in
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Table 4. Plasma concentrations of luteinizing hormone (LH) and follicle stimulating
hormone (FSH) in rats exposed to 2-bromopropane for 9 weeks
0 ppm 100 ppm 300 ppm 1,000 ppm
n 7 8 7 9
LH (ng/ml) 0.56 ± 0.31 0.43 ± 0.41 0.38 ± 0.27 0.32 ± 0.14
FSH (ng/ml) 7.77 ± 1.13 7.70 ± 3.98 8.59 ± 0.78 9.54 ± 1.91
Fig. 2. Ovaries from rats in control and treated groups.  (a) Control: Normal Graafian follicles (Gf) and corpus luteum (Cl).  Big
and small arrows indicate secondary and primordial follicles, respectively.  (b) 300 ppm: Increased number of atretic
follicles accompanied by reduced number of normal follicles.  (c-1) 1,000 ppm: Normal Graafian follicles and corpora lutea
still remained in the ovary of rat showing constant vaginal diestrus and occasional estrus.  Atretic antral follicle (Af).
(c-2) 1,000 ppm: The ovary in persistent estrous rats consisted mainly of tissues derived from atretic follicles.  Viable
oocytes were not found in the remaining cystic follicles.  There were no newly formed corpora lutea.  (Hematoxylin-Eosin
staining; original magnification × 125.)
Table 5. Plasma concentrations of LH and FSH in the rats which showed diestrous
smears on the day of autopsy
0 ppm 100 ppm 300 ppm 1,000 ppm
n 7 7 7 5
LH (ng/ml) 0.56 ± 0.31 0.42 ± 0.44 0.38 ± 0.27 0.26 ± 0.14
FSH (ng/ml) 7.77 ± 1.13 7.79 ± 4.29 8.59 ± 0.78 9.30 ± 1.59
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contrast to the effect on spermatogenesis10).  Extensive
studies are needed on female reproductive toxicity of
structurally related compounds, especially in a chronic or
subchronic study design.
In conclusion, 2-bromopropane is as toxic to the female
reproductive system as it is to the male’s.  The amenorrhea
observed among Korean workers in an electronics factory1)
could be primarily attributable to 2-bromopropane exposure.
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